The Mayo Clinic and the American Society of Plastic Surgeons have both published information about a rare cancer with possible ties to breast implants as concerns continue to grow over breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
Initially, BIA-ALCL was thought to be a mostly European concern as the condition was generally associated with women who had received textured rather than smoothly surfaced ...
continue reading...The death toll formally attributed to breast implant-associated anaplastic large cell lymphoma now stands at 36, although it could be higher. Three new fatalities have occurred within the same six months and just weeks before the implants implicated in the deaths were set to be recalled.
The implants in question were made by Allergan prior to its acquisition by AbbVie. The Biocell textured ...
continue reading...After millions upon millions of procedures performed over the span of several decades, the safety of the implants used in breast augmentation and reconstructive surgeries have been thrust to the forefront of thought for both the medical community and the women who underwent the operations. For most women exploring the idea of implants in the late-20th to early-21st centuries, concerns over the procedure were limited to ...
Much of the initial concern over textured breast implant associated cases of anaplastic large cell lymphoma started out focused on non-U.S. markets. While the vast majority of U.S.-based breast implant procedures utilize smooth implants, the opposite held true for much of the rest of the market.
Six U.S. women who had textured breast implants used in their augmentation procedures have sued Allergan over their increased cancer risk and allege ...
continue reading...Approximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
The extraordinarily rare cancer first became ...
continue reading...
